EPISTAXIS
Clinical trials for EPISTAXIS explained in plain language.
Never miss a new study
Get alerted when new EPISTAXIS trials appear
Sign up with your email to follow new studies for EPISTAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a transplant drug stop HHT nosebleeds? small study tests sirolimus
Disease control CompletedThis small pilot study tested the safety and effectiveness of the oral drug sirolimus for reducing nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). Ten adults with moderate to severe nosebleeds took 2 mg of sirolimus daily for 3 months. Researchers tracked b…
Matched conditions: EPISTAXIS
Phase: PHASE2 • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Which tube causes fewer nosebleeds in kids? study compares two options
Knowledge-focused CompletedThis study looked at 98 children aged 3-18 having dental surgery under general anesthesia. Doctors compared a standard spiral breathing tube with a specially shaped nasal tube to see which caused fewer nosebleeds and was easier to insert. The goal is to find the safest way to pla…
Matched conditions: EPISTAXIS
Phase: NA • Sponsor: Dicle University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC